The UAB NF Program is internationally recognized for its contributions to outstanding clinical care, research, and education related to all forms of neurofibromatosis (NF1, NF2, and schwannomatosis). We are the national coordinating center for the NF Clinical Trials Consortium, funded by the Department of Defense to perform clinical trials for all forms of neurofibromatsis.
HudsonAlpha and UAB awarded NIH training grant
The University of Alabama at Birmingham and HudsonAlpha Institute for Biotechnology have been awarded a National Institutes of Health Ruth L. Kirschstein National Research Service Award to train postdoctoral fellows who have earned an M.D. and/or a Ph.D. The UAB-HudsonAlpha Genomic Medicine Research Training Program is designed to recruit trainees from various disciplines and provide mentorship and clinical research training in genomic medicine. At HudsonAlpha, the program will provide up to two years of support for postdoctoral trainees who choose to learn and work at the Institute.Read more ...
Clinical Services: Our goal is to deliver outstanding care for patients and families through integrated clinical and laboratory services. For some conditions, we are considered a national and international referral source.
Research: We seek to expand knowledge and create new applications through laboratory and clinical research along the continuum from fundamental studies to preclinical investigations, to bench-to bedside translation, to clinical practice and community implementation.